animenews: Sarepta says FDA delays decision on muscle-wasting disorder drug

Affichage des articles dont le libellé est Sarepta says FDA delays decision on muscle-wasting disorder drug. Afficher tous les articles

lundi 8 février 2016

Sarepta says FDA delays decision on muscle-wasting disorder drug

(Reuters) - Sarepta Therapeutics Inc said the U.S. Food and Drug Administration had delayed a decision on its lead drug for a rare muscle-wasting disorder.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro

animenews

تعديل

lundi 8 février 2016

Sarepta says FDA delays decision on muscle-wasting disorder drug

التسميات

أرشيف المدونة الإلكترونية